MXPA03005888A - Base libre de amlodipina. - Google Patents
Base libre de amlodipina.Info
- Publication number
- MXPA03005888A MXPA03005888A MXPA03005888A MXPA03005888A MXPA03005888A MX PA03005888 A MXPA03005888 A MX PA03005888A MX PA03005888 A MXPA03005888 A MX PA03005888A MX PA03005888 A MXPA03005888 A MX PA03005888A MX PA03005888 A MXPA03005888 A MX PA03005888A
- Authority
- MX
- Mexico
- Prior art keywords
- amlodipine
- free base
- solution
- process according
- solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25861300P | 2000-12-29 | 2000-12-29 | |
US80935101A | 2001-03-16 | 2001-03-16 | |
PCT/NL2001/000947 WO2002053135A1 (en) | 2000-12-29 | 2001-12-31 | Amlodipine free base |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03005888A true MXPA03005888A (es) | 2005-04-19 |
Family
ID=26946752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03005888A MXPA03005888A (es) | 2000-12-29 | 2001-12-31 | Base libre de amlodipina. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1345901A2 (ru) |
AU (1) | AU2001294354A1 (ru) |
BR (1) | BR0116558A (ru) |
CA (1) | CA2433366C (ru) |
CZ (1) | CZ20031779A3 (ru) |
DE (2) | DE20116723U1 (ru) |
ES (1) | ES2277960T3 (ru) |
MX (1) | MXPA03005888A (ru) |
WO (2) | WO2002053535A2 (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2433284A1 (en) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Reference standards and processes for determining the purity or stability of amlodipine maleate |
BE1014450A6 (nl) * | 2000-12-29 | 2003-10-07 | Bioorg Bv | Werkwijze voor het maken van amlodipine, derivaten daarvan en voorlopers daarvoor. |
AR037565A1 (es) * | 2001-11-21 | 2004-11-17 | Synthon Bv | Formas de sales de amlodipina y procedimientos para prepararlas. |
NL1019882C2 (nl) * | 2002-02-01 | 2003-08-04 | Synthon Licensing | Amlodipine vrije base. |
ES2211317B1 (es) * | 2002-11-18 | 2005-10-16 | Finaf 92, S.A. | Compuestos intermedios para la obtencion de principios activos antihipertensivos y procedimientos correspondientes. |
KR100558505B1 (ko) * | 2003-01-27 | 2006-03-07 | 한미약품 주식회사 | 안정한 무정형 암로디핀 캠실레이트, 이의 제조방법 및이를 포함하는 경구투여용 조성물 |
WO2004075825A2 (en) * | 2003-02-28 | 2004-09-10 | Ranbaxy Laboratories Limited | Dosage forms of amlodipine and processes for their preparation |
CH697952B1 (de) * | 2003-07-25 | 2009-03-31 | Siegfried Generics Int Ag | Verfahren zur Reinigung der freien Amlodipinbase. |
WO2005023769A1 (en) * | 2003-09-04 | 2005-03-17 | Cipla Limited | Process for the preparation of amlodipine salts |
KR100604034B1 (ko) * | 2003-10-08 | 2006-07-24 | 주식회사유한양행 | 암로디핀 유리염기를 함유한 구강 속붕해정 및 그의 조성물 |
WO2007131759A1 (en) * | 2006-05-15 | 2007-11-22 | Lek Pharmaceuticals D.D. | A process for the preparation of amlodipine benzenesulfonate |
EP1975167A1 (en) | 2007-03-30 | 2008-10-01 | Esteve Quimica, S.A. | Acetone solvate of phthaloyl amlodipine |
WO2011117876A1 (en) | 2010-03-26 | 2011-09-29 | Fdc Limited | An improved process for the preparation of amlodipine free base and acid addition salts thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK161312C (da) * | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
PL140573B1 (en) | 1982-12-21 | 1987-05-30 | Pfizer | Method of obtaining new dihydropyridine derivatives |
DE3544211A1 (de) * | 1985-12-13 | 1987-06-19 | Bayer Ag | Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE4305454A1 (de) * | 1993-02-23 | 1994-08-25 | Bayer Ag | Klotzverfahren mit einer Phthalocyaninmischung |
GB9317773D0 (en) * | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
GB0008332D0 (en) * | 2000-04-04 | 2000-05-24 | Pfizer Ltd | Treament |
GB0020842D0 (en) * | 2000-08-23 | 2000-10-11 | Pfizer Ltd | Therapeutic compositions |
-
2001
- 2001-08-15 CZ CZ20031779A patent/CZ20031779A3/cs unknown
- 2001-08-15 WO PCT/NL2001/000601 patent/WO2002053535A2/en not_active Application Discontinuation
- 2001-08-15 EP EP01974983A patent/EP1345901A2/en not_active Withdrawn
- 2001-08-15 AU AU2001294354A patent/AU2001294354A1/en not_active Abandoned
- 2001-10-04 DE DE20116723U patent/DE20116723U1/de not_active Ceased
- 2001-12-31 ES ES01995820T patent/ES2277960T3/es not_active Expired - Lifetime
- 2001-12-31 BR BR0116558-5A patent/BR0116558A/pt not_active Application Discontinuation
- 2001-12-31 MX MXPA03005888A patent/MXPA03005888A/es active IP Right Grant
- 2001-12-31 WO PCT/NL2001/000947 patent/WO2002053135A1/en active IP Right Grant
- 2001-12-31 CA CA002433366A patent/CA2433366C/en not_active Expired - Fee Related
- 2001-12-31 DE DE60125981T patent/DE60125981T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2001294354A1 (en) | 2002-07-16 |
WO2002053135A1 (en) | 2002-07-11 |
EP1345901A2 (en) | 2003-09-24 |
BR0116558A (pt) | 2003-10-28 |
WO2002053535A3 (en) | 2003-01-23 |
CZ20031779A3 (cs) | 2004-10-13 |
CA2433366C (en) | 2006-01-24 |
ES2277960T3 (es) | 2007-08-01 |
DE60125981T2 (de) | 2007-10-18 |
AU2001294354A8 (ru) | 2005-10-06 |
DE60125981D1 (de) | 2007-02-22 |
DE20116723U1 (de) | 2002-01-17 |
CA2433366A1 (en) | 2002-07-11 |
WO2002053535A2 (en) | 2002-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5086069B2 (ja) | 重硫酸アタザナビルおよび新規形態の製造方法 | |
CN101035759B (zh) | N-(4-氟苄基)-n-(1-甲基哌啶-4-基)-n’-(4-(2-甲基丙氧基)苯基甲基)脲及其酒石酸盐的合成和晶形 | |
CA2433288C (en) | Process for making amlodipine maleate | |
HU227589B1 (en) | Crystal form of (s)-omeprazole | |
BG61323B2 (bg) | Производни на пиперидина,тяхното получаване и използването им като лекарства | |
EP1167355B1 (en) | A crystalline form of celecoxib | |
TWI445697B (zh) | 塔適那偉(atazanavir)硫酸氫鹽之製法及其新穎的形式 | |
CA2433366C (en) | Amlodipine free base | |
BG64746B1 (bg) | Състав за орално приложение, съдържащ левосимендан | |
KR20070083679A (ko) | 약학적으로 순수한 비정질 도네페닐 염산염의 제조를 위한정제된 도네페질 말레산염의 용도 | |
US20030191347A1 (en) | Venlafaxine base | |
IL101358A (en) | Tiagabine hydrochloride crystalline monohydrate, its preparation and pharmaceutical preparations containing the same | |
AU2004238537A1 (en) | Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same | |
US7335380B2 (en) | Amlodipine free base | |
CA2433190C (en) | Amlodipine hemimaleate | |
CA2164296C (en) | Heterocyclic chemistry | |
EP1858847A1 (en) | Stable form i donepezil hydrochloride and process for its preparation and use in pharmaceutical compositions | |
EP1355632B1 (en) | Amlodipine free base | |
BE1014922A3 (nl) | Amlodipine als vrije base. | |
NL1019882C2 (nl) | Amlodipine vrije base. | |
SI21121A (sl) | Prosta baza amlodipina | |
US20040198794A1 (en) | Ondansetron forms and processes of making the same | |
CZ2002432A3 (cs) | Volná amlodinová báze | |
AU2001100436A4 (en) | Amlodipine hemimaleate | |
AU2001100432A4 (en) | Process for making amlodipine maleate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |